Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women

Journal of Endocrinology

Volumn 150, Issue SUPPL., 1996, Pages

  Diamond, P ^a   Cusan, L ^a   Gomez, J L ^a   Belanger A ^a   Labrie, F ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE;

ADULT; AGED; ANDROGEN SYNTHESIS; BODY FAT; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DRUG EFFECT; ESTROGEN SYNTHESIS; FEMALE; HORMONE SUBSTITUTION; HUMAN; MUSCLE MASS; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL;

ADIPOSE TISSUE; AGED; BLOOD GLUCOSE; BODY CONSTITUTION; CHOLESTEROL; CHOLESTEROL, HDL; DEHYDROEPIANDROSTERONE; FEMALE; GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MIDDLE AGED; MUSCLE, SKELETAL; POSTMENOPAUSE; SEBACEOUS GLANDS; SEX HORMONE-BINDING GLOBULIN; SKINFOLD THICKNESS;

EID: 0029949143     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Abadie JM, Wright B, Correa G, Browne ES, Porter JR & Svec F 1993 Effect of dehydroepiandrosterone on neurotransmitter levels and appetite regulation of the obese Zucker rat. Diabetes 42 662-669.
2. Bagdade JD, Bierman EL & Porte Jr D 1967 The significance of basal insulin in the evaluation of the insulin response to glucose in diabetic and non-diabetic subjects. Journal of Clinical Investigation 46 1549-1557
3. Barrett-Connor E, Khaw KT & Yen SSC 1986 A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. New England Journal of Medicine 315 1519-1524.
4. Bélanger A, Candas B, Dupont A, Cusan L, Diamond P, Gomez JL & Labrie F 1994 Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. Journal of Clinical Endocrinology and Metabolism 79 1086-1090.
5. Belchetz PE 1995 Hormonal treatment of postmenopausal women. New England Journal of Medicine 330 1062-1071.
6. Bruckert E, Carvalho de Sousa J, Giral P, Soriac Chapman MJ, Caen J & deGennes JL 1989 Interrelationship of plasma triglyceride and coagulant factor VII levels in monotriglyceridemic hypercholesterolemia. Atherosclerosis 75 129-134.
7. Chen C, Poulin R & Labrie F 1996 Large Shionogi tumors lose their responsiveness to Flutamide treatment. Journal of Steroid Biochemistry and Molecular Biology (In Press).
8. Cleary MP & Zisk J 1986 Antiobesity effect of two different levels of dehydroepiandrosterone in lean and obese middle-aged female Zucker rats. International Journal of Obesity 10 193-204.
9. Cleary MP, Shepherd A & Jenks B 1984 Effect of dehydroepiandrosterone in lean and obese Zucker rats. Journal of Nutrition 114 1242-1251.
10. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B & Speizer FE 1995 The use of estrogens and progestins and the risk of breast cancer in postmenopausal women New England Journal of Medicine 332 1589-1593
11. Coleman DL, Leiter EH & Schwizer RW 1982 Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 31 830-833
12. Coleman DL, Schwizer RW & Leiter EH 1984 Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants in aged normal mice Diabetes 33 26-33.
13. Daughaday WH & Rotwein P 1989 Insulin-like growth factors 1 and II: peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocrine Reviews 10 68-90.
14. De Pergola G, Giagulli VA, Garruti G, Cospite MR, Giorgino F, Ciganrelli M & Giorgino R 1991 Low dehydroepiandrosterone circulating levels in premenopausal obese women with very high body mass index. Metabolism 40 187-190.
15. Desbuquois B & Aurbach GD 1971 Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. Journal of Clinical Endocrinology and Metabolism 37 732-738.
16. Després JP & Lamarche B 1993 Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutrition Research Reviews 6 137-159.
17. Després JP, Moorjani S, Lupien PJ, Tremblay T, Nadeau A & Bouchard C 1990 Regional distribution of body fat, plasma lipoproteins and cardiovascular disease. Arteriosclerosis 10 497-511.
18. Diamond P, Brisson GR, Candas B & Peronnet F 1989 Trait anxiety, submaximal physical exercise and blood androgens. European Journal of Applied Physiology 58 699-704.
19. Harel Z & Tannenbaum GS 1995 Long-term alterations in growth hormone and insulin secretion after temporary dietary protein restriction in early life in the rat Pediatric Research 38 747-753.
20. Hulley SB, Rosenman RH, Bawold RH & Brand RJ 1980 Epidemiology as a guide to clinical decision. The association between triglyceride and coronary heart disease. New England Journal of Medicine 302 1383-1389.
21. Hunt K, Vessey M, McPherson K & Coleman M 1987 Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. British Journal of Obstetrics and Gynaecology 94 620-635.
22. Labrie F 1991 Intracrinology. Molecular and Cellular Endocrinology 78 C113-C118.
23. Labrie F, Dupont A & Bélanger A 1985 Complete androgen blockade for the treatment of prostate cancer. In Important Advances in Oncology, pp 193-217. Eds VT de Vita, S Hellman & SA Rosenberg. Philadelphia: JB Lippincott
24. Labrie C, Bélanger A & Labrie F 1988 Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 123 1412-1417.
25. Labrie C, Flamand M, Bélanger A & Labrie F 1996 High bioavailability of dehydroepiandrosterone administered percutaneously in the rat. Journal of Endocrinology 150 (Suppl) S107-S118.
26. Li S, Yan X, Bélanger A & Labrie F 1993 Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat. Breast Cancer Research and Treatment 29 203-217.
27. MacEwen EG & Kurzman ID 1991 Obesity in the dog: role of the adrenal steroid dehydroepiandrosterone (DHEA) Journal of Nutrition 121 S51-S55.
28. Migeon CJ, Keller AR, Lawrence B & Shepart II TH 1957 Dehydroepiandrosterone and androsterone levels in human placenta. Effect of age and sex: day-to-day and diurnal variations. Journal of Clinical Endocrinology and Metabolism 17 1051-1062
29. Mohan PF & Cleary MP 1988 Effect of short-term DHEA administration on liver metabolism of lean and obese rodents. American Journal of Physiology 255 E1-E8
30. Moorjani S, Dupont A, Labrie F, Lupien PJ, Brun C & Gagné C 1985 Plasma lipoprotein concentrations following complete androgen blockade in prostate cancer patients. Clinical and Investigative Medicine 8 A-46.
31. Moorjani S, Dupont A, Labrie F, Lupien PJ, Gagné C, Brun C, Giguère M, Bélanger A & Cusan L 1988 Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with LHRH agonist. Journal of Clinical Endocrinology and Metabolism 66 314-322.
32. Mortola JF & Yen SS 1990 The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 71 1360-1367.
33. Murphy LJ & Ghahary A 1990 Uterine insulin-like growth factor-I: regulation of expression and its role in estrogen-induced uterine proliferation Endocrine Reviews 11 443-453.
34. Nestler JE, Barlascini CO, Clore JN & Blackard WG 1988 Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. Journal of Clinical Endocrinology and Metabolism 66 57-61.
35. Oertel GW & Benes P 1972 The effects of steroids on glucose-6-phosphate deshydrogenase. Journal of Steroid Biochemistry 3 493-496.
36. Orentreich N, Brind JL, Rizer RL & Vogelman JH 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood Journal of Clinical Endocrinology and Metabolism 59 551-555.
37. Pochi PE & Strauss JS 1974 Endocrinologic control of the development and activity of the human sebaceous gland. Journal of Investigative Dermatology 62 191-201.
38. Pochi PE, Strauss JS & Downing DT 1979 Age-related changes in sebaceous gland activity. Journal of Investigative Dermatology 73 108-111.
39. Rosner W 1990 The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocrine Reviews 11 80-91.
40. Sjöström L, Kirst H, Cederblad A & Tylén M 1986 Determination of total adipose tissue and body fat in women by computed tomography, 40K and tritium. American Journal of Physiology 13 E736-E745.
41. Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A & Clemmons DR 1993 Use of insulin-like growth factor-binding protein 2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children Journal of Clinical Endocrinology and Metabolism 77 1294-1299.
42. Tagliaferro AR, Davis JR, Truchon S & Van Hamont N 1986 Effects of dehydroepiandrosterone acetate on metabolism, body weight and composition of male and female rats. Journal of Nutrition 116 1977-1983.
43. Vermeulen A, Deslypene JP, Schelthout W, Verdonck L & Rubens R 1982 Adrenocortical function in old age: response to acute adrenocorticotropin stimulation. Journal of Clinical Endocrinology and Metabolism 54 187-191.
44. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V & Sacks F 1991 Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. New England Journal of Medicine 325 1196-1204.
45. Welle S, Jozefowicz R & Statt M 1990 Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans Journal of Clinical Endocrinology and Metabolism 71 1259-1264.